Syndecan-1 regulates the biological activities of interleukin-34

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1853, Issue 5, 2015, Pages 1010-1021

  Segaliny, Aude I ^a,b   Brion, Regis ^a,b,c   Mortier, Erwan ^b   Maillasson, Mike ^b   Cherel, Michel ^b   Jacques, Yannick ^b   Le Goff, Benoît ^a,b,c   Heymann, Dominique ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Co receptor chondroitin sulphate; Cytokine bioavailability; Interleukin 34; M CSFR; M2a macrophage; Syndecan 1

Indexed keywords

CHONDROITIN SULFATE; COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR 1 RECEPTOR; COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 34; N ACETYLGALACTOSAMINE 4 SULFATASE; PROTEOGLYCAN; RNA; SYNDECAN 1; UNCLASSIFIED DRUG; INTERLEUKIN DERIVATIVE; INTERLEUKIN-34, HUMAN; PROTEIN BINDING; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE; SMALL INTERFERING RNA;

ARTICLE; BIOLOGICAL ACTIVITY; BONE MARROW CELL; BONE MARROW CULTURE; CELL DIFFERENTIATION; CELL MIGRATION; CELL MIGRATION ASSAY; CELL SURFACE; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; FLOW CYTOMETRY; GENETIC TRANSFECTION; HEK293 CELL LINE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SURFACE PLASMON RESONANCE; WESTERN BLOTTING; BIOLOGICAL MODEL; CELL LINE; CELL MOTION; CYTOLOGY; DRUG EFFECTS; METABOLISM; PHOSPHORYLATION;

CELL LINE; CELL MOVEMENT; CHONDROITIN SULFATES; HUMANS; INTERLEUKINS; MACROPHAGE COLONY-STIMULATING FACTOR; MODELS, BIOLOGICAL; MYELOID CELLS; PHOSPHORYLATION; PROTEIN BINDING; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 5; RNA, SMALL INTERFERING; SYNDECAN-1;

EID: 84923163430     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2015.01.023     Document Type: Article

References (53)

1. Bourette R.P., Rohrschneider J.A.J. Early events in M-CSF receptor signaling. Growth Factors 2000, 17:155-166.
2. F.J., Stanley E.R. CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol. 2004, 14:628-638.
3. Lin H., Lee E., Hestir K., Leo C., Huang M., Bosch E., Halenbeck R., Wu G., Zhou A., Behrens D., Hollenbaugh D., Linnemann T., Qin M., Wong J., Chu K., Doberstein S.K., Williams L.T. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 2008, 320:807-811.
4. Foucher E.D., Blanchard S., Preisser L., Garo E., Ifrah N., Guardiola P., Delneste Y., Jeannin P. IL-34 induces the differentiation of human monocytes into immunosuppressive macrophages, antagonistic effects of GM-CSF and IFNγ. PLoS One 2013, 8:e56045.
5. Baud'Huin M., Renault R., Charrier C., Riet A., Moreau A., Brion R., Gouin F., Duplomb L., Heymann D. Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis. J. Pathol. 2010, 221:77-86.
6. Chemel M., Le Goff B., Brion R., Cozic C., Berreur M., Amiaud J., Bougras G., Touchais S., Blanchard F., Heymann M.F., Berthelot J.M., Verrecchia F., Heymann D. Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients. Ann. Rheum. Dis. 2012, 71:50-154.
7. Boström E.A., Lundberg P. The newly discovered cytokine IL-34 is expressed in gingival fibroblasts, shows enhanced expression by pro-inflammatory cytokines, and stimulates osteoclast differentiation. PLoS ONE 2013, 8:e81665.
8. Roth P., Stanley E.R. The biology of CSF-1 and its receptor. Curr. Top. Microbiol. Immunol. 1992, 181:141-167.
9. Felix J., Elegheert J., Gutsche I., Shkumatov A.V., Wen Y., Bracke N., Pannecoucke E., Vandenberghe I., Devreese B., Svergun D.I., Pauwels E., Vergauwen B., Savvides S.N. Human IL-34 and CSF-1 establish structurally similar extracellular assemblies with their common hematopoietic receptor. Structure 2013, 21:528-539.
10. Ma X., Lin W.Y., Chen Y., Stawicki S., Mukhyala K., Wu Y., Martin F., Bazan J.F., Starovasnik M.A. Structural basis for the dual recognition of helical cytokines IL-34 and CSF-1 by CSF-1R. Structure 2012, 20:676-687.
11. Sherr C.J. Colony-stimulating factor-1 receptor. Blood 1990, 75:1-12.
12. Liu H., Leo C., Chen X., Wong B.R., Williams L.T., Lin H., He X. The mechanism of shared but distinct CSF-1R signaling by the non-homologous cytokines IL-34 and CSF-1. Biochim. Biophys. Acta 2012, 1824:938-945.
13. Chihara T., Suzu S., Hassan R., Chutiwitoonchai N., Hiyoshi M., Motoyoshi K., Kimura F., Okada S. IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation. Cell Death Differ. 2010, 17:1917-1927.
14. Dai X.M., Ryan G.R., Hapel A.J., Dominguez M.G., Russell R.G., Kapp S., Sylvestre V., Stanley E.R. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 2002, 99:111-120.
15. Yoshida H., Hayashi S., Kunisada T., Ogawa M., Nishikawa S., Okamura H., Sudo T., Shultz L.D., Nishikawa S. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990, 345:442-444.
16. Wiktor-Jedrzejczak W., Bartocci A., Ferrante A.W., Ahmed-Ansari A., Sell K.W., Pollard J.W., Stanley E.R. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:4828-4832.
17. Wei S., Nandi S., Chitu V., Yeung Y.G., Yu W., Huang M., Williams L.T., Lin H., Stanley E.R. Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells. J. Leukoc. Biol. 2010, 88:495-505.
18. Ginhoux F., Greter M., Leboeuf M., Nandi S., See P., Gokhan S., Mehler M.F., Conway S.J., Ng L.G., Stanley E.R., Samokhvalov I.M., Merad M. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010, 330:841-845.
19. Greter M., Lelios I., Pelczar P., Hoeffel G., Price J., Leboeuf M., Kündig T.M., Frei K., Ginhoux F., Merad M., Becher B. Stroma-derived interleukin-34 controls the development and maintenance of Langerhans cells and the maintenance of microglia. Immunity 2012, 37:1050-1060.
20. Wang Y., Szretter K.J., Vermi W., Gilfillan S., Rossini C., Cella M., Barrow A.D., Diamond M.S., Colonna M. IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat. Immunol. 2012, 13:753-760.
21. Heymann D. Interleukin-34: an enigmatic cytokine. IBMS BoneKEy 2010, 7:406-413.
22. Nandi S., Gokhan S., Dai X.M., Wei S., Enikolopov G., Lin H., Mehler M.F., Stanley E.R. The CSF-1 receptor ligands IL-34 and CSF-1 exhibit distinct developmental brain expression patterns and regulate neural progenitor cell maintenance and maturation. Dev. Biol. 2012, 367:100-113.
23. Vandesompele J., Preter K.D., Pattyn F., Poppe B., Roy N.V., Paepe A.D., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3. (research0034).
24. Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., Mueller R., Nolan T., Pfaffl M.W., Shipley G.L., Vandesompele J., Wittwer C.T. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 2009, 55:611-622.
25. Tejedor F., Ballesta J.P. Iodination of biological samples without loss of functional activity. Anal. Biochem. 1982, 127:143-149.
26. Godard A., Heymann D., Raher S., Anegon I., Peyrat M.A., Le Mauff B., Mouray E., Gregoire M., Virdee K., Soulillou J.P. High and low affinity receptors for human interleukin for DA cells/leukemia inhibitory factor on human cells. Molecular characterization and cellular distribution. J. Biol. Chem. 1992, 267:3214-3222.
27. Nandi S., Cioce M., Yeung Y.G., Nieves E., Tesfa L., Lin H., Hsu A.W., Halenbeck R., Cheng H.Y., Gokhan S., Mehler M.F., Stanley E.R. Receptor-type protein tyrosine phosphatase zeta is a functional receptor for interleukin-34. J. Biol. Chem. 2013, 288:21972-21986.
28. Fujikawa A., Fukada M., Makioka Y., Suzuki R., Chow J.P.H., Matsumoto M., Noda M. Consensus substrate sequence for protein-tyrosine phosphatase receptor type Z. J. Biol. Chem. 2011, 286:37137-37146.
29. Couchman J.R. Transmembrane signaling proteoglycans. Annu. Rev. Cell Dev. Biol. 2010, 26:89-114.
30. Sanderson R.D., Bernfield M. Molecular polymorphism of a cell surface proteoglycan: distinct structures on simple and stratified epithelia. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:9562-9566.
31. Saunders S., Jalkanen M., O'Farrell S., Bernfield M. Molecular cloning of syndecan, an integral membrane proteoglycan. J. Cell Biol. 1989, 108:1547-1556.
32. Marynen P., Zhang J., Cassiman J.J., Van den Berghe H., David G. Partial primary structure of the 48- and 90-kilodalton core proteins of cell surface-associated heparan sulfate proteoglycans of lung fibroblasts. Prediction of an integral membrane domain and evidence for multiple distinct core proteins at the cell surface of human lung fibroblasts. J. Biol. Chem. 1989, 264:7017-7024.
33. Carey D.J., Evans D.M., Stahl R.C., Asundi V.K., Conner K.J., Garbes P., Cizmeci-Smith G. Molecular cloning and characterization of N-syndecan, a novel transmembrane heparan sulfate proteoglycan. J. Cell Biol. 1992, 117:191-201.
34. David G., van der Schueren B., Marynen P., Cassiman J.J., van den Berghe H. Molecular cloning of amphiglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cells. J. Cell Biol. 1992, 118:961-969.
35. Yeaman C., Rapraeger A.C. Membrane-anchored proteoglycans of mouse macrophages: P388D1 cells express a syndecan-4-like heparan sulfate proteoglycan and a distinct chondroitin sulfate form. J. Cell. Physiol. 1993, 157:413-425.
36. Karasneh G.A., Ali M., Shukla D. An important role for syndecan-1 in herpes simplex virus type-1 induced cell-to-cell fusion and virus spread. PLoS ONE 2011, 6:e25252.
37. Kresse H., Schönherr E. Proteoglycans of the extracellular matrix and growth control. J. Cell. Physiol. 2001, 189:266-274.
38. Jastrebova N., Vanwildemeersch M., Lindahl U., Spillmann D. Heparan sulfate domain organization and sulfation modulate FGF-induced cell signaling. J. Biol. Chem. 2010, 285:26842-26851.
39. Takazaki R., Shishido Y., Iwamoto R., Mekada E. Suppression of the biological activities of the epidermal growth factor (EGF)-like domain by the heparin-binding domain of heparin-binding EGF-like growth factor. J. Biol. Chem. 2004, 279:47335-47343.
40. Kemp L.E., Mulloy B., Gherardi E. Signalling by HGF/SF and Met: the role of heparan sulphate co-receptors. Biochem. Soc. Trans. 2006, 34:414-417.
41. Dai J., Rabie A.B.M. VEGF: an essential mediator of both angiogenesis and endochondral ossification. J. Dent. Res. 2007, 86:937-950.
42. Niehrs C. The complex world of WNT receptor signalling. Nat. Rev. Mol. Cell Biol. 2012, 13:767-779.
43. Rider C.C. Heparin/heparan sulphate binding in the TGF-β cytokine superfamily. Biochem. Soc. Trans. 2006, 34:458.
44. Sampaio N.G., Yu W., Cox D., Wyckoff J., Condeelis J., Stanley E.R., Pixley F.J. Phosphorylation of CSF-R Y721 mediates its association with PI3K to regulate macrophage motility and enhancement of tumor invasion. J. Cell Sci. 2011, 124:2021-2031.
45. Rapraeger A.C. Synstatin: a selective inhibitor of the syndecan-1-coupled IGF1R-αvβ3 integrin complex in tumorigenesis and angiogenesis. FEBS J. 2013, 280:2207-2215.
46. Massena S., Christoffersson G., Hjertström E., Zcharia E., Vlodavsky I., Ausmees N., Rolny C., Li J.P., Phillipson M. A chemotactic gradient sequestered on endothelial heparan sulfate induces directional intraluminal crawling of neutrophils. Blood 2010, 116:1942-1931.
47. Mosheimer B.A., Kaneider N.C., Feistritzer C., Djanani A.M., Sturn D.H., Patsch J.R., Wiedermann C.J. Syndecan-1 is involved in osteoprotegerin-induced chemotaxis in human peripheral blood monocytes. J. Clin. Endocrinol. Metab. 2005, 90:2964-2971.
48. Bensliman-Ahmin Z., Poirier F., Delomenie C., Lokajczyk A., Grelac F., Galy-Fauroux I., Mohamedi A., Fischer A.M., Heymann D., Lutomski D., Boisson-Vidal C. Mechanistic study of the pro-angiogenic effect of osteoprotegerin. Angiogenesis 2013, 16:575-593.
49. Kelly T., Suva L.J., Nicks K.M., MacLeod V., Sanderson R.D. Tumor-derived syndecan-1 mediates distal cross-talk with bone that enhances osteoclastogenesis. J. Bone Miner. Res. 2010, 25:1295-1304.
50. Baud'huin M., Charrier C., Bougras G., Brion R., Lezot F., Padrines M., Heymann D. Proteoglycans and osteolysis. Methods Mol. Biol. 2012, 836:323-337.
51. Cook J., Hagemann T. Tumour-associated macrophages and cancer. Curr. Opin. Pharmacol. 2013, 13:595-601.
52. Averbeck M., Gebbhardt C., Anderegg U., Termeer C., Sleeman J.P., Simon J.C. Switch in syndecan-1 and syndecan-4 expression controls maturation associated dendritic cell motility. Exp. Dermatol. 2007, 16:580-589.
53. Yeaman C., Rapraeger A.C. Post-transcriptional regulation of syndecan-1 expression by cAMP in peritoneal macrophages. J. Cell Biol. 1993, 122:941-950.